KILITCH DRUGS (INDIA)
|
The Current P/S Ratio of KILITCH DRUGS (INDIA) is 2.61.
| Share Price | ₹154.2 | Apr 27,2026 |
| Market Cap | ₹539.7 Cr | |
| Sales-TTM | ₹207.1 Cr | TTM-Consolidated Results |
| Price/Sales | 2.61x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of KILITCH DRUGS (INDIA)
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹539.7 Cr] as on Apr 27,2026
(/) Sales [ ₹207.1 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 2.61x ]
Thus, for KILITCH DRUGS (INDIA) , the investors are currently willing to pay '2.61 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of KILITCH DRUGS (INDIA) !
The chart below summarizes the trend in P/S Ratio of KILITCH DRUGS (INDIA) over the last five years.
Historical PS (Price/Sales) ratio chart of KILITCH DRUGS (INDIA)
PS Ratio Performance Analysis for KILITCH DRUGS (INDIA)
- KILITCH DRUGS (INDIA) 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 2.53x.
- KILITCH DRUGS (INDIA) 's operated at median p/e ratio of 2.29x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, KILITCH DRUGS (INDIA) 's p/e ratio peaked in Mar2024 at 4.06x.
- KILITCH DRUGS (INDIA) 's p/e ratio hit its five-year low in Mar2023 of 1.56x.
How does KILITCH DRUGS (INDIA) 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| KILITCH DRUGS (INDIA) | 207.1 | 2.61 | 539.7 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 56,809.1 | 7.32 | 415,997.0 |
| DIVIS LABORATORIES LTD | 10,314.0 | 16.67 | 171,900.0 |
| CIPLA LTD | 28,351.1 | 3.75 | 106,397.0 |
| TORRENT PHARMACEUTICALS LTD | 12,742.0 | 11.21 | 142,804.0 |
| DR REDDYS LABORATORIES LTD | 34,682.2 | 3.21 | 111,389.0 |
| MANKIND PHARMA LTD | 13,914.1 | 6.72 | 93,546.9 |
| ZYDUS LIFESCIENCES LTD | 26,089.3 | 3.59 | 93,765.9 |
| LUPIN LTD | 26,150.5 | 4.06 | 106,260.0 |
| AUROBINDO PHARMA LTD | 33,181.9 | 2.48 | 82,337.3 |
| ABBOTT INDIA LTD | 6,824.1 | 7.93 | 54,085.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs KILITCH DRUGS (INDIA) 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.48x |
| Max industry PS | 16.67x |
| Median industry PS | 4.06x |
| Average industry PS | 6.32x |
You may also like the below Video Courses